𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy, safety, and tolerability in patients switched to PEG (40 kDa) IFN α-2a (PEGASYS®) after discontinuation from interferon alfa-2b plus ribavirin (REBETRON™) combination therapy for chronic hepatitis C

✍ Scribed by Perrillo, Robert P.; Rothstein, Kenneth D.; Alam, Imtiaz; Thuluvath, Paul J.; Palmer, Melissa; Pockros, Paul J.; Cantwell, Susan; Pappas, Stephen C.


Book ID
124137002
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
180 KB
Volume
120
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES